Stacy Seng

Stacy Enxing Seng currently works at Contego Medical, Inc., as Chairman, Cala Health, Inc., as Chairman, LivaNova, Inc., as Director, Fogarty Institute For Innovation, as Director, LivaNova Plc, as Independent Director from 2019, Vesper Medical, Inc., as Director from 2021, Imperative Care, Inc., as Director from 2022, Fogarty Innovation LLC, as Independent Director, Corza Medical Inc., as Independent Non-Executive Director from 2022, LSV Capital Management LLC, as Operating Partner from 2016, and Sonova AG, as Member-Supervisory Board from 2014.
Ms. Seng also formerly worked at Sonova Holding AG, as Vice Chairman from 2021 to 2025, Hill-Rom Holdings, Inc., as Independent Director from 2015 to 2021, Solace Therapeutics, Inc., as Director, CV Ingenuity Corp., as Director, Claret Medical, Inc., as Director in 2018, Spirox, Inc., as Director, Fire One, Inc., as Director from 2014 to 2019, preCARDIA, Inc., as Independent Director, Go Red For Women, as Director from 2014 to 2019, ev3, Inc., as President-US Peripheral Vascular & SVP from 2009 to 2011, Covidien Unlimited Co., as President-Vascular Therapies from 2012 to 2014, and Boston Scientific Scimed, Inc., as Vice President-Marketing from 1999 to 2001.
Ms. Seng received her undergraduate degree in 1986 from Michigan State University, graduate degree in 2016 from Stanford University, and Masters Business Admin degree in 1993 from Harvard Business School.